November 14, 2017 Regulatory Promore Pharma Signs Out-licensing Agreement with Transdermal Therapeutic Technologies for its Peptide DPK-060
November 14, 2017 Regulatory Promore Pharma tecknar utlicensieringsavtal för DPK-060 med Transdermal Therapeutic Technologies
October 30, 2017 Non Regulatory Promore Pharma slutför ett omfattande europeiskt samarbete avseende DPK-060
October 30, 2017 Non Regulatory Promore Pharma Completes Extensive European Collaboration Regarding DPK-060
September 12, 2017 Non Regulatory Promore Pharma presents at the symposium for hard-to-heal wounds in connection with Nordic Life Science Days
September 12, 2017 Non Regulatory Promore Pharma presenterar på symposium för svårläkta sår i anslutning till Nordic Life Science Days
June 30, 2017 Non Regulatory Promore Pharma väntar godkännade för listning på Nasdaq First North under nästa vecka
June 26, 2017 Non Regulatory New share issue in Promore Pharma raises 76 MSEK ahead of listing on Nasdaq First North
June 7, 2017 Non Regulatory Promore Pharma Carries Out a Share Issue Prior to Listing on Nasdaq First North
May 16, 2017 Non Regulatory Promore Pharma inlämnar ansökan om att genomföra en fas III-studie i Indien
April 26, 2017 Non Regulatory Promore Pharma utser Marianne Dicander Alexandersson till ny styrelseledamot och meddelar planer för notering på Nasdaq First North
April 26, 2017 Non Regulatory Promore Pharma AB elects Marianne Dicander Alexandersson as New Board Member and outlines plans for IPO